Beruflich Dokumente
Kultur Dokumente
Daniel Faurholt-Jepsen, Nyagosya Range, George Praygod, Jeremiah Kidola, Maria Faurholt-Jepsen, Martine G, Aabye, John Changalucha, Dirk L. Christensen, Torben Martinussen, Henrik Krarup, Danie R Witte, Ase B Andersen, Henrik Friis (2012:12)
Abstract
Background :
Methods :
Results :
Conclussion :
Background
Due to the association between diabetes
and pulmonary TB, diabetes may threaten the control of TB. In a prospective cohort study nested in a nutrition trial, we investigated the role of diabetes on changes in anthropometry, grip strength, and clinical parameters over a five months fol
Methods
Cohort study, 2 large randomized, double blind, controlled nutrition interventional study with all patient diagnosed and treated for TB according to international guidelines. Measurement :
TB patient : use Spot-morning-spot sample Weight & height : barefoot, minimal clothing Waist circumference : lower costa-iliac crest AFA & AMA : use TST & MUAC Grip strength : digital hand dynamometer Diabetes : FBG > 108 mg/dL ; 2 h pp > 198 mg/dL HIV : ELISA CD4 : flow cytometry
Results
Of 1205 TB patients, the mean (standard
deviation) age was 36,6 (13,0) years, 40,5% were females, 48,9% were HIV co-infected, and 16,3% had diabetes. TB patient with diabetes co-morbidity experienced a lower weight gain at two (1,3kg) and five months (1,0kg). Similarly, the increase in the level of hemoglobin was lower among TB with diabetes co-morbidity after two (0,6 g/dL)and five months (0,5 g/dL)of TB treatment, respectively
Background characteristics
Patient w/o diabetes Age (SD) Female sex HIV infection TB status PTBPTB+ Ethnic Group Msukuma tribe Other tribe 459 (45,6) 584 (54,4) 94 (47,7) 103 (52,3) 0,582 * 339 (33,6) 669 (66,4) 83 (32,0) 134 (68,0) 0,65 * 36,3 (12,8) 404 (40,1) 507 (50,3) Patient w/ diabetes 38,0 (13,8) 89 (45,2) 97 (49,2) p 0,083 0,183 0,786
0,605
Married
Divorced Occupation Farmer/fisherman Employed Housewife Unemployed
528 (52,8)
223 (22,3) 394 (39,2) 356 (35,4) 120 (11,9) 51 (5,1)
108 (55,4)
45 (23,1) 75 (38,3) 74 (37,8) 23 (11,7) 9 (4,6) 0,974 * * *
P * 0.191
Muslim
Smoking Never Past smoker Current smoker Take alcohol No Yes
223 (22,1)
* 675 (82,9) 110 (85,9) 216 (84,7) * 533 (82,9) 475 (84,5)
38 (19,3)
* 139 (17,1) 18 (14,1) 39 (15,3) * 110 (17,1) 87 (15,5)
*
* 0.60 * * * *
P * *
2 months
Increase 5 months Increase
54,8
3,0 57,1 5,3
55,1
1,7 * 57,7 4,3 *
*
* 0,001 * * 0,007
Difference 1,3
Difference 1,0
P * *
2 months
Increase 5 months Increase
19,8
1,1 20,7 1,9
19,9
0,6 * 20,9 1,6 *
*
* 0,001 * * 0,012
Difference 0,5
Difference 0,3
Patients w/o Patients w/ diabetes diabetes Waist circumference, cm * Baseline 72,1 * 73,7
P * *
2 months
Increase Difference 5 months Increase Difference
74,5
2,4 0,3 76,3 4,2 0,1
75,8
2,1 * 77,8 4,1 *
*
* 0,512 * * 0.697
P * *
2 months
Increase 5 months Increase
37,2
2,7 40,7 6,2
37,4
1,7 * 41,0 5,4 *
*
* 0,100 * * 0,164
Difference 0,9
Difference 0,8
P * *
2 months
Increase Difference 5 months Increase Difference
9,2
1,1 0.4 10,4 2,3 0,2
9,0
0,8 * 10,4 2,1 *
*
* 0,297 * * 0,524
Patients w/o diabetes Grip Strength, kg Baseline 2 months Increase Difference 5 months Increase Difference * 25,8 27,6 1,8 0,2 30,5 4,7 0,3
P * * * * 0,610 * * 0,550
Patients w/o diabetes Whiteblood cell count Baseline 2 months Increase Difference 5 months Increase Difference * 6.4 4.7 -1.7 0.02 4.3 -2.2 -0.03
P * * * * 0.918 * * 0.889
Patients w/o diabetes Neutrophil count Baseline 2 months Increase Difference 5 months Increase Difference * 4.1 2.3 -1.8 0.1 1.8 -2.3 0.1
P * * * * 0.493 * * 0.658
P * *
2 months
Increase Difference 5 months Increase Difference
477.5
51.7 25.7 436.2 10.3 22.8
435.1
25.9 * 396.6 -12.5 *
*
* 0.362 * * 0.431
non diabetes2
diabetes
Mean hemoglobin
non diabetes
diabetes
Discussion
Diabetes co-morbidity was associated with
delayed recovery of weight and hemoglobin level within the first two and 5 months of TB treatment not affected by diabetes
Functional recovery based on grip strength Low level of hemoglobin at baseline are
primarily inflamation-induced anemia from on-going HIV and TB infection, the hemoglobin level is expected to rise during recovery
and five kg over the two and five months treatment period, but diabetes patient had a one kg weight deficit months) were not effected by diabetes comorbiditiy.
Conclussion
TB patients initiating TB treatment with
diabetes co-morbidity may experience slower recovery from their TB disease such as anthropometry and hemoglobin
return to work, and thus the delay may not only have beneficial health outcomes, but also economically consequences for low income families burdened by TB